Literature DB >> 33504077

Identifying the Hidden Population: Former Intravenous Drug Users Who Are No Longer in Contact with Services. "Ask a Friend".

Sarah R Donaldson1,2, Andrew Radley1,2, John F Dillon1,3.   

Abstract

People who, after a period of drug use, have changed their lifestyle and left substance use behind them are a hidden population within our communities. Lack of contact with drug services may mean that they are not tested for hepatitis C (HCV) infection through service-led initiatives and, therefore, may be exposed to the chronic morbidity and risk of death inherent with a legacy of HCV infection. This study utilized respondent-driven sampling (RDS) in a novel fashion to find those at historical risk of HCV. The social networks of people with a history of drug use were mapped, and individuals not currently in contact with services were invited to come forward for testing by members of their social network. The study used a reference group to inform study methodology and communication methods to reach out to this hidden population. One hundred and nine individuals received dry blood spot tests for HCV, 17.4% were antibody positive. Fifty one individuals met the inclusion criteria for this study. One hundred and twenty three invite-to-test coupons were issued; however, only one wave of recruitment consisting of one participant resulted from this method. Using RDS in historical social networks was not effective in this study and did not reach this hidden population and increase testing for HCV. This study is registered with clinicaltrials.gov (Ref NCT03697135).

Entities:  

Keywords:  PWID; dry blood spot; hepatitis C; models of care; respondent-driven sampling; social networks

Year:  2021        PMID: 33504077      PMCID: PMC7911884          DOI: 10.3390/diagnostics11020170

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  18 in total

1.  Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.

Authors:  V D Hope; M Hickman; S L Ngui; S Jones; M Telfer; M Bizzarri; F Ncube; J V Parry
Journal:  J Viral Hepat       Date:  2011-04       Impact factor: 3.728

2.  Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.

Authors:  Andrew Radley; Marijn de Bruin; Sarah K Inglis; Peter T Donnan; Adrian Hapca; Stephen T Barclay; Andrew Fraser; John F Dillon
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-06-08

3.  Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study.

Authors:  Abu S Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Keith Sabin; Kathleen Gallagher; Don C Des Jarlais
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

4.  Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: field experiences in international settings.

Authors:  Lisa Grazina Johnston; Mohsen Malekinejad; Carl Kendall; Irene M Iuppa; George W Rutherford
Journal:  AIDS Behav       Date:  2008-06-06

Review 5.  Ethical considerations in HIV/AIDS biobehavioral surveys that use respondent-driven sampling: illustrations from Lebanon.

Authors:  Jocelyn DeJong; Ziyad Mahfoud; Danielle Khoury; Farah Barbir; Rema Adel Afifi
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

6.  Approaches to Recruiting 'Hard-To-Reach' Populations into Re-search: A Review of the Literature.

Authors:  Abdolreza Shaghaghi; Raj S Bhopal; Aziz Sheikh
Journal:  Health Promot Perspect       Date:  2011-12-20

Review 7.  Understanding barriers to hepatitis C virus care and stigmatization from a social perspective.

Authors:  Carla Treloar; Jake Rance; Markus Backmund
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

8.  "They got their program, and I got mine": a cautionary tale concerning the ethical implications of using respondent-driven sampling to study injection drug users.

Authors:  Greg Scott
Journal:  Int J Drug Policy       Date:  2008-01-15

9.  Implementation and analysis of respondent driven sampling: lessons learned from the field.

Authors:  Abu S Abdul-Quader; Douglas D Heckathorn; Keith Sabin; Tobi Saidel
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

10.  Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment-ADVANCE HCV protocol study.

Authors:  Sarah K Inglis; Lewis Jz Beer; Christopher Byrne; Amy Malaguti; Emma Robinson; Christian Sharkey; Kirsty Gillings; Brian Stephens; John F Dillon
Journal:  BMJ Open       Date:  2019-08-08       Impact factor: 2.692

View more
  1 in total

Review 1.  Viral hepatitis in 2021: The challenges remaining and how we should tackle them.

Authors:  Rebecca Dunn; Aaron Wetten; Stuart McPherson; Mhairi C Donnelly
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.